Psoriasis Vulgaris in Human Immunodeficiency Virus Infected Patient: A Case Report

Rahmadewi Rahmadewi, Maya Wardiana

Abstract views = 843 times | downloads = 394 times


Background: Psoriasis vulgaris (PV) is a chronic inflammatory skin disease characterized by erythematous thick scaly plaques. PV in human immunodeficiency virus (HIV) infected patient can give severe clinical features and challenging to treat since the treatment are immunosuppressive drugs. Purpose: To report a case of psoriasis vulgaris in HIV infected patient. Case: A 39 year-old man complained about scaly redness patches on his back and elbow that spread accompanied by burning sensation. From physical examination, on almost all over his body there were erythematous plaques sharply marginated with thick scales. Histopathologic examination from skin biopsy revealed parakeratosis, acanthosis, with psoriasiform hyperplasia and Munro’s microabscesses consistent to PV. The patient was treated with methotrexate tablets. After 8 days hospitalization, white plaque appeared on his tongue. Potassium hydroxide examination (KOH) 10% and 3 methods HIV test was done with positive result. Because of HIV positive methotrexate was stopped. Antiretroviral therapy (ART) was given and its combination with desoximetasone 0.25% cream after 10 days gave a good result for the PV. Discussion: The pathophysiology of PV in HIV infected patient seems to be conflicting due to the involvement of T cell lymphocyte in both diseases. Treatment for PV in HIV infected patient should consider the probability of the immunosuppressive effect of the drugs that can worsen the HIV infection. ART is recommended as the treatment for PV. Conclusion: Psoriatic lesion in this patient responded well to ART and desoximetasone 0.25% cream. PV in HIV infected patient requires certain management considering immunological status and immunosuppressive treatment. Early diagnosis of these comorbid condition help to determine appropriate management.


Psoriasis vulgaris; human immunodeficiency virus; antiretroviral therapy;

Full Text:



Gudjonsson JE, Elder JT. Psoriasis. In: Goldsimth L, Katz S, Gilchrest B, Paller A, Leffell D, Wolff K, editors. Fitzpatrick’s Dermatology in General Medicine. New York: McGraw-Hill Medical; 2012. p. 197–231.

World Health Organization. Global report on psoriasis. 1st ed. Geneva: WHO Press; 2016. p.

Ceccarelli AM, Rullo EV, Vaccaro M, Facciolà A, Aleo FD, Paolucci IA, et al. HIV associated psoriasis: epidemiology, pathogenesis and management Authors: Dhermatol Ther 2018; e12806: 1–21.

Alpalhao M, Borges-Costa J, Filipe P. Psoriasis in HIV infection : an update. Int J STD AIDS 2019; 0(0): 1–9.

Morar N, Willis-owen SA, Maurer T, Bunker CB. HIV-associated psoriasis : pathogenesis , clinical features , and management. Lancet Infect Dis 2010; 10(7): 470–8.

Fife DJ, Waller JM, Jeffes EW, Koo JY. Unraveling the paradoxes of HIV-associated psoriasis: A review of T-cell subsets and cytokine profiles. Dermatol Online J 2007; 13(2): 4.

Tan J, Pina A, Borges-Costa J. Skin Diseases in the Era of Highly Active Antiretroviral Therapy : A Retrospective Study of 534 Patients. J Int Assoc Provid AIDS Care 2018; 17(1): 1–5.

Menon K, Voorhees AS Van, Bebo BF, Gladman DD. Psoriasis in patients with HIV infection : From the Medical Board of the National Psoriasis Foundation. J Am Dermatology 2009; 62(2): 291–9.

Nakamura M, Abrouk M, Farahnik B, Zhu TH, Bhutani Ti. Psoriasis Treatment in HIV-Positive Patients : A Systematic Review of Systemic Immunosuppressive Therapies. Cutis 2018; 101(1): 38–43.


  • There are currently no refbacks.

Copyright (c) 2019 Berkala Ilmu Kesehatan Kulit dan Kelamin

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



Lisensi Creative Commons
Creations are distributed below Lisensi Creative Commons Atribusi-NonKomersial 4.0 Internasional.

View My Stats